128 related articles for article (PubMed ID: 26488531)
1. Alemtuzumab, Fludarabine, Low-Dose TBI, and Double Umbilical Cord Transplant for Primary Graft Failure in a Patient with Recurrent HLH.
Hege K; Quigg T; Delgado D
Pediatr Blood Cancer; 2016 Feb; 63(2):361-3. PubMed ID: 26488531
[TBL] [Abstract][Full Text] [Related]
2. Reduced-intensity conditioning in unrelated donor cord blood transplantation for familial hemophagocytic lymphohistiocytosis.
Nishi M; Nishimura R; Suzuki N; Sawada A; Okamura T; Fujita N; Kanai R; Yano J; Adachi S; Yasumi T; Sato E; Yasutomo K; Ishii E; Ohga S
Am J Hematol; 2012 Jun; 87(6):637-9. PubMed ID: 22488407
[TBL] [Abstract][Full Text] [Related]
3. Durable Chimerism and Long-Term Survival after Unrelated Umbilical Cord Blood Transplantation for Pediatric Hemophagocytic Lymphohistiocytosis: A Single-Center Experience.
Patel SA; Allewelt HA; Troy JD; Martin PL; Driscoll TA; Prasad VK; Kurtzberg J; Page KM; Parikh SH
Biol Blood Marrow Transplant; 2017 Oct; 23(10):1722-1728. PubMed ID: 28647558
[TBL] [Abstract][Full Text] [Related]
4. Fludarabine-based reduced-intensity conditioning regimen for hematopoietic stem cell transplantation in primary hemophagocytic lymphohistiocytosis.
Hamidieh AA; Pourpak Z; Hashemi S; Yari K; Fazlollahi MR; Movahedi M; Behfar M; Moin M; Ghavamzadeh A
Eur J Haematol; 2014 Apr; 92(4):331-6. PubMed ID: 24330187
[TBL] [Abstract][Full Text] [Related]
5. An intermediate alemtuzumab schedule reduces the incidence of mixed chimerism following reduced-intensity conditioning hematopoietic cell transplantation for hemophagocytic lymphohistiocytosis.
Marsh RA; Kim MO; Liu C; Bellman D; Hart L; Grimley M; Kumar A; Jodele S; Myers KC; Chandra S; Leemhuis T; Mehta PA; Bleesing JJ; Davies SM; Jordan MB; Filipovich AH
Biol Blood Marrow Transplant; 2013 Nov; 19(11):1625-31. PubMed ID: 24035782
[TBL] [Abstract][Full Text] [Related]
6. Haploidentical transplantation as a promising therapy for relapsed hemophagocytic lymphohistiocytosis in an older adult patient.
Ayala E; LaFave D; Nishihori T; Kharfan-Dabaja MA
Hematol Oncol Stem Cell Ther; 2018 Jun; 11(2):96-98. PubMed ID: 27352259
[TBL] [Abstract][Full Text] [Related]
7. Feasibility of salvage cord blood transplantation following fludarabine, melphalan and low-dose TBI for graft rejection after hematopoietic stem cell transplantation.
Ishiyama K; Takeda J; Kondo T; Sugimoto N; Kawabata H; Kitano T; Takaori-Kondo A
Bone Marrow Transplant; 2016 Jul; 51(7):985-7. PubMed ID: 26878662
[No Abstract] [Full Text] [Related]
8. Low-dose total-body irradiation and alemtuzumab-based reduced-intensity conditioning regimen results in durable engraftment and correction of clinical disease among children with chronic granulomatous disease.
Mehta B; Mahadeo K; Kapoor N; Abdel-Azim H
Pediatr Transplant; 2015 Jun; 19(4):408-12. PubMed ID: 25845644
[TBL] [Abstract][Full Text] [Related]
9. Reduced-intensity conditioning for hematopoietic cell transplant for HLH and primary immune deficiencies.
Allen CE; Marsh R; Dawson P; Bollard CM; Shenoy S; Roehrs P; Hanna R; Burroughs L; Kean L; Talano JA; Schultz KR; Pai SY; Baker KS; Andolina JR; Stenger EO; Connelly J; Ramirez A; Bryant C; Eapen M; Pulsipher MA
Blood; 2018 Sep; 132(13):1438-1451. PubMed ID: 29997222
[TBL] [Abstract][Full Text] [Related]
10. Complete donor T cell chimerism predicts lower relapse incidence after standard double umbilical cord blood reduced-intensity conditioning regimen allogeneic transplantation in adults.
Peterlin P; Delaunay J; Guillaume T; Gastinne T; Mahé B; Dubruille V; Blin N; Le Bourgeois A; Brissot E; Lodé L; Le Gouill S; Moreau P; Mohty M; Chevallier P
Biol Blood Marrow Transplant; 2015 Jan; 21(1):180-4. PubMed ID: 25175796
[TBL] [Abstract][Full Text] [Related]
11. Hematopoietic stem cell transplantation for familial hemophagocytic lymphohistiocytosis and Epstein-Barr virus-associated hemophagocytic lymphohistiocytosis in Japan.
Ohga S; Kudo K; Ishii E; Honjo S; Morimoto A; Osugi Y; Sawada A; Inoue M; Tabuchi K; Suzuki N; Ishida Y; Imashuku S; Kato S; Hara T
Pediatr Blood Cancer; 2010 Feb; 54(2):299-306. PubMed ID: 19827139
[TBL] [Abstract][Full Text] [Related]
12. Reduced intensity allogeneic umbilical cord blood transplantation in children and adolescent recipients with malignant and non-malignant diseases.
Bradley MB; Satwani P; Baldinger L; Morris E; van de Ven C; Del Toro G; Garvin J; George D; Bhatia M; Roman E; Baxter-Lowe LA; Schwartz J; Qualter E; Hawks R; Wolownik K; Foley S; Militano O; Leclere J; Cheung YK; Cairo MS
Bone Marrow Transplant; 2007 Oct; 40(7):621-31. PubMed ID: 17660841
[TBL] [Abstract][Full Text] [Related]
13. T cell-depleted related HLA-mismatched peripheral blood stem cell transplantation as salvage therapy for graft failure after single unit unrelated donor umbilical cord blood transplantation.
Moscardó F; Romero S; Sanz J; Sanz MA; Montesinos P; Lorenzo I; Solves P; Carpio N; Sanz GF
Biol Blood Marrow Transplant; 2014 Jul; 20(7):1060-3. PubMed ID: 24685578
[TBL] [Abstract][Full Text] [Related]
14. A Case of Refractory Langerhans Cell Histiocytosis Complicated with Hemophagocytic Lymphohistiocytosis Rescued by Cord Blood Transplantation with Reduced-intensity Conditioning.
Washio K; Muraoka M; Kanamitsu K; Oda M; Shimada A
Acta Med Okayama; 2017 Jun; 71(3):249-254. PubMed ID: 28655945
[TBL] [Abstract][Full Text] [Related]
15. Outcomes of Children with Hemophagocytic Lymphohistiocytosis Given Allogeneic Hematopoietic Stem Cell Transplantation in Italy.
Messina C; Zecca M; Fagioli F; Rovelli A; Giardino S; Merli P; Porta F; Aricò M; Sieni E; Basso G; Ripaldi M; Favre C; Pillon M; Marzollo A; Rabusin M; Cesaro S; Algeri M; Caniglia M; Di Bartolomeo P; Ziino O; Saglio F; Prete A; Locatelli F
Biol Blood Marrow Transplant; 2018 Jun; 24(6):1223-1231. PubMed ID: 29410181
[TBL] [Abstract][Full Text] [Related]
16. [Reactivation of familial hemophagocytic lymphohistiocytosis after non-myeloablative cord blood stem cell transplantation resulted in the early graft failure].
Yanagimachi M; Goto H; Yokosuka T; Kajiwara R; Kuroki F; Ito S; Yokota S
Rinsho Ketsueki; 2007 Jun; 48(6):495-500. PubMed ID: 17633098
[TBL] [Abstract][Full Text] [Related]
17. Hemophagocytic Lymphohistiocytosis and Graft Failure Following Unrelated Umbilical Cord Blood Transplantation in Children.
Noguchi M; Inagaki J
J Pediatr Hematol Oncol; 2020 Aug; 42(6):e440-e444. PubMed ID: 32287100
[TBL] [Abstract][Full Text] [Related]
18. Unrelated umbilical cord blood transplantation using a TBI/FLAG conditioning regimen for adults with hematologic malignancies.
Okada M; Fujimori Y; Misawa M; Kai S; Nakajima T; Okikawa Y; Satake A; Itoi H; Takatsuka H; Itsukuma T; Nishioka K; Tamaki H; Ikegame K; Hara H; Ogawa H
Biol Blood Marrow Transplant; 2008 Aug; 14(8):896-903. PubMed ID: 18640573
[TBL] [Abstract][Full Text] [Related]
19. Safety and outcome after fludarabine-thiotepa-TBI conditioning for allogeneic transplantation: a prospective study of 30 patients with hematologic malignancies.
van Besien K; Devine S; Wickrema A; Jessop E; Amin K; Yassine M; Maynard V; Stock W; Peace D; Ravandi F; Chen YH; Cheung T; Vijayakumar S; Hoffman R; Sosman J
Bone Marrow Transplant; 2003 Jul; 32(1):9-13. PubMed ID: 12815472
[TBL] [Abstract][Full Text] [Related]
20. Salvage transplantation for allograft failure using fludarabine and alemtuzumab as conditioning regimen.
Bolaños-Meade J; Luznik L; Muth M; Matsui WH; Huff CA; Smith BD; Levy MY; Kasamon YL; Swinnen LJ; Powell JD; Brodsky RA; Ambinder RF; Jones RJ; Fuchs EJ
Bone Marrow Transplant; 2009 Mar; 43(6):477-80. PubMed ID: 18978825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
